Press

Unlearn on shaving millions off clinical trial budgets with digital twins

How Is Artificial Intelligence Changing the Clinical Trials Landscape?

How AI-Generated Digital Twins Are Speeding Up Clinical Development

ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial

Health AI 35: What to know, who to watch

Unlearn Announces Leadership Transition to Accelerate Commercial Growth and AI Innovation

How digital twins could support more affordable Alzheimer’s research

Unlearn’s AI-Powered Clinical Trials with AbbVie and Johnson & Johnson

Steve Herne Joins Unlearn’s Executive Team as Chief Commercial Officer

Pharma’s cultural barriers could blunt AI progress despite pressures for more efficient drug approvals

The AI-Generated Population Is Here, and They’re Ready to Work

As AI proliferates in pharma, regulators look to catch up in clinical trials

Beyond the Black Box: Tailoring AI Regulation in Healthcare

Unlearn CEO: Digital twins could slash clinical trial patient enrollment by 25% or more

Charles Fisher, Ph.D., CEO & Founder of Unlearn – Interview Series

Unlearn launches TwinRCT 3.0 to enhance Phase II trials

Exploring Functional Uses Of AI In Life Sciences

Unlearn’s TwinRCT Solution Update Enhances Phase 2 Trial Decision-Making Power

How AI is being used to accelerate clinical trials

Here are the top 10 Bay Area AI deals that closed in February